Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Choksi AsiaBOM:530427 +1.56%52 Gross Margin % is 26.71% as of Mar. 2026, which is 23% above its 10-year median of 21.78. GuruFocus rates BOM:530427 with a GF Score™ of 52/100. The stock has 8 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Choksi Asia ranks worse than 88.71% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Choksi Asia's Gross Profit for the
three
months ended in Mar. 2026 was ₹31.7 Mil. Choksi Asia's Revenue for the
three
months ended in Mar. 2026 was ₹118.6 Mil. Therefore, Choksi Asia's Gross Margin % for the quarter that ended in Mar. 2026 was 26.71%.
Warning Sign:
Choksi Asia Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.6%.
The historical rank and industry rank for Choksi Asia's Gross Margin % or its related term are showing as below:
BOM:530427'
s Gross Margin % Range Over the Past 10 Years
Min: 15.36 Med: 21.78 Max: 31.42
Current: 21.19
During the past 13 years, the highestGross Margin % of Choksi Asia was 31.42%. The lowest was 15.36%. And the median was 21.78%.
BOM:530427's Gross Margin % is ranked worse than 88.71% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs BOM:530427: 21.19
Choksi Asia had a gross margin of 26.71% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Choksi Asia was -2.60% per year.
Choksi Asia (BOM:530427) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Choksi Asia had a gross margin of 26.71% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Choksi Asia Gross Margin % Related Terms
Choksi Asia Gross Margin % Historical Data
* Premium members only.
The historical data trend for Choksi Asia's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530427 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Choksi Asia's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Choksi Asia Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Choksi Asia's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Choksi Asia's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Choksi Asia (BOM:530427) has a Gross Margin % of 26.71% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Choksi Asia and its competitors. This is 23% above median its historical median of 21.78. Over the past decade, Choksi Asia's Gross Margin % has ranged from 15.36 to 31.42. According to the industry distribution chart, Choksi Asia ranks #715 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 88.7%.
Is Choksi Asia's Gross Margin % too high?
Choksi Asia's current Gross Margin % of 26.71% is 23% above median its 10-year median of 21.78. Over the past 10 years, this metric has ranged from a low of 15.36 to a high of 31.42. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Choksi Asia's value of 26.71% is 48.7% below this industry median. Based on the distribution chart, Choksi Asia ranks #715 out of 806 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Choksi Asia has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Choksi Asia's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Choksi Asia ranks #715 out of 806 companies for Gross Margin %. This places Choksi Asia in the lower half of its industry. The industry median Gross Margin % is 52.12. Choksi Asia's value of 26.71% is 48.7% below this benchmark. Historically, Choksi Asia's own Gross Margin % has ranged from 15.36 to 31.42 over the past decade. While the company's 10-year median is 21.78 vs. the industry median of 52.12, Choksi Asia has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Choksi Asia's current Gross Margin % of 26.71% is 48.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Choksi Asia and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Choksi Asia's current Gross Margin % is 26.71%, which is 23% above median its own 10-year median of 21.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Asia stock overvalued right now?
Choksi Asia (BOM:530427) has a current Gross Margin % of 26.71%. The current Gross Margin % is 26.71%, which is 23% above median its 10-year median of 21.78 and 48.7% below the Medical Devices & Instruments industry median of 52.12. Choksi Asia's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Choksi Asia (BOM:530427), the current Gross Margin % is 26.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Choksi Asia Ltd formerly Choksi Imaging Ltd is an India-based company engaged in the manufacturing of photosensitized materials, medical X-rays, and other healthcare products. The company sells and derives revenue from products like X-ray films, ultrasound, computed radiography systems, specialty X-ray films, etc. In addition, the company also offers maintenance services for X-ray processors, equipment, and computer radiography systems. The firm provides various photographic, and ultrasonic sound services in association with Protec, Medtron, and others.
52GF Score
Get the complete analysis for BOM:530427
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530427 has been successfully added to your 
